Review question
The primary research question for this review is: can we provide a reliable, robust and evidence-based conclusion from animal experiments to identify that acupuncture may increase the ATP activity in brain disease?
The secondary research question is: which factors would influence the results of acupuncture for ATP release?
Protocol registration and reporting
This project has been registered on the International Prospective Register of Systematic Review (PROSPERO) platform, and the registration number is CRD 42020184971. The reporting of this protocol has been in accordance with the reporting guidance provided in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols (PRISMA-P) statement [37]. The details have been shown in additional file 1.
Search strategy
We will systematically retrieve PubMed, Embase, web of Science, the China National Knowledge Infrastructure (CNKI), the Chinese Science and Technology Periodical Database (VIP) and Wan Fang database from the inception dates to July 25, 2020. MeSH terms and free-text terms will be employed during search. Important Search terms will include: brain disease, basal ganglia diseases, hypothalamic diseases, brain abscess, brain damage, brain neoplasms, acupuncture, needle, manual acupuncture, electroacupuncture, ATP, adenosine triphosphate, energy, mitochondrial respiratory enzyme and so on. The full search strategy was listed in additional file 2. There will be no limitation to language. In addition, we will perform additional search to ensure that more eligible studies can be retrieved, such as citation searches, contacting experts, and manual searches. Literature retrieval will be carried out independently by two researchers (SLH/ZHL).
Inclusion and exclusion criteria
Studies will be included in this analysis if satisfied with the following requirements: (ⅰ) study design: controlled studies with a separate control group. (ⅱ) animals: animal studies correlated with brain diseases. There is no restricts for animals and model establishment methods. (ⅲ) inventions: all timings, frequencies and durations of acupuncture treatment (electroacupuncture or traditional manual acupuncture) will be eligible for inclusion. (ⅳ) comparison: model group will be set as comparison. (ⅴ) outcomes: the primary outcomes are ATP activity, ATP content, Na+-k+-ATPase activity, and Ca2+ activity. Secondary outcomes are the context of glucose (Glu) and mitochondrial respiratory enzyme activity including complex I, complex II, complex III, complex V and cytochrome c (Cyt c) enzyme activity etc.
Studies will be excluded if met any of the following criteria: (ⅰ) duplicated articles, case reports, review articles or letters; (ⅱ) lack of sufficient data or information; (ⅲ) comparison of different types of acupuncture; (ⅳ) interventions such as ear acupuncture, tongue acupuncture, scalp acupuncture and catgut embedding therapy. Inclusion and exclusion criteria for this study has been shown in Table 1.
Table 1
inclusion and exclusion criteria for the research questions.
Inclusion criteria
|
Exclusion criteria
|
Animals:
animal studies correlated with brain disease will be included. And there is no restricts for animals and model establishment methods.
Inventions:
all timings, frequencies and durations of acupuncture treatment will be eligible for inclusion.
Comparison:
model group of each study will be utilized as comparison.
Outcomes:
the primary outcomes are ATP activity, ATP content, Na+-k—ATPase activity, and Ca2+ activity. Secondary outcomes are the context of glucose (Glu) and mitochondrial respiratory enzyme activity including complex I, complex II, complex III, complex V and cytochrome c (Cyt c) enzyme activity.
Study design:
controlled studies with a separate control group
Language
No limitations
|
(ⅰ) duplicated articles, case reports, review articles or letters;
(ⅱ) lack of sufficient data or information;
(ⅲ) Comparison of different type acupuncture.
|
Data management and data extraction
We will use Endnote X7 (Bod 7072, Thomson Reuters) to perform the data management. After eliminating duplications, two researchers will independently screen titles and abstracts for potentially relevant studies. Full text of these reviews will be downloaded and read for eligible included studies based on inclusion and exclusion criteria. Two researchers will cross-check after completion to avoid mis-entry. Any discrepancies will be discussed by a third reviewer.
Two researchers (YLP/ZYL) will independently complete the data extraction. Discrepancies should be discussed with a third reviewer (LJ). A data extraction form would be developed in advance using excel, covering: (ⅰ) General information (title, author, country and language); (ⅱ) Study characteristics (disease, species of rats, number of animals, model establishment, (types, timings, frequencies and durations of acupuncture)); (ⅲ) Outcomes.
Evaluation of risk of bias
The SYstematic Review Centre for Laboratory animal Experimentation (SYRCLE) is an adapted version of the Cochrane Risk of Bias tool and has been adjusted for aspects of bias that play a specific role in animal intervention studies [38]. We will assess the risk of bias of the included studies with SYRCLE tool by two independently reviewers (ZDL/LYX). This instrument addressed 10 types of bias: sequence generation, baseline characteristics, allocation concealment, random housing, blinding of caregivers and/or investigators, random outcome assessment; blinding of outcome assessor, incomplete outcome data, selective outcome reporting and other sources of bias. Each item will be rated as “yes” (low risk of bias), “no” (high risk of bias) and “unclear” (if insufficient details are obtained). We will cross check to eliminate the mis-entry. Discrepancies will be discussed with a third reviewer (LJ).
Statistical analysis
Descriptive syntheses
Study characteristic and findings of included literatures will be summarized. The results will be presented in a tabular format.
Meta-analyses
We will analyze the extracted data using Review Manager 5.3 and Stata.12 software. Since the major outcomes are continuous variables, the mean and standard deviation will be calculated with 95% confidence interval (CI). Heterogeneity will be tested using the Q-test and I2 test (I2<25%--low, 25-50%--moderate, and >50%--high degree of heterogeneity). Given heterogeneity is inevitable across studies, random effects meta-analysis will be used to synthesize results. Pooled results will be evaluated and a 2-sided P value<0.05 is considered to indicate statistical significance.
Meta-regression and subgroup analysis
Meta-regression and subgroup analysis will be utilized to identify the source of heterogeneity based as follows: the species of animals, the category of brain diseases, the method of model establishment and the timings, frequencies and durations of acupuncture.
sensitivity analysis
We plan to conduct sensitivity analysis to clarify the robustness of conclusion. If a high heterogeneity existed, we will include or exclude the studies where there is some ambiguity as to whether they meet the inclusion criteria.
Publication bias
If there are 10 or more eligible studies included, we will use funnel plot and egger’s test to assess the publication bias.
Reporting
We plan to follow with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) (http://www.prisma-statement.org/) to produce a flow chart (Fig.2) and to report our results. Reasons for exclusion will also be listed.
Amendments
If there are any amendments to this protocol, we will reflect in edits to the PROSPERO registration, and present with the findings of the review.